Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CPRI
NYSE:CPRILuxury

Capri Holdings Q3 Loss Reinforces Concerns Over Trailing US$1.2b Earnings Hole

Capri Holdings (CPRI) has just posted its Q3 2026 numbers, with quarterly revenue of US$856 million and a basic EPS loss of US$0.28, alongside trailing 12 month EPS of US$10.14 in losses on US$4.4 billion of revenue. Over recent periods the company has seen revenue move between US$848 million and US$1.3 billion per quarter while EPS has swung from a profit of US$0.47 to losses of more than US$5 per share, setting a wide range for earnings outcomes that keeps the focus firmly on...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro Leans Into Fandom With New Licensing Deals And Campaigns

Hasbro (NasdaqGS:HAS) has announced new entertainment licensing deals tied to the upcoming live action Street Fighter movie and Netflix's KPop Demon Hunters. The company is rolling out associated merchandise, collectibles, and games, alongside a MY LITTLE PONY "Chase the Magic" collaborative sweepstakes that lets fans help shape a new character. These moves reflect a focus on fan engagement and franchise based products across films, streaming content, and long running toy brands. Hasbro,...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

A Look At MoonLake Immunotherapeutics (MLTX) Valuation After Mixed Analyst Calls And FDA Fast Track Decision

What triggered the latest move in MoonLake Immunotherapeutics MoonLake Immunotherapeutics (MLTX) has come into focus after a mix of analyst calls and an FDA update on its lead drug, sonelokimab, highlighted contrasting views on the company’s clinical and regulatory outlook. Goldman Sachs cut its rating, citing approval risk following the VELA-2 outcome in hidradenitis suppurativa, while the FDA granted Fast Track status for sonelokimab in palmoplantar pustulosis, supported by Phase 2 LEDA...
OM:BOL
OM:BOLMetals and Mining

A Look At Boliden (OM:BOL) Valuation After A Strong Multi Period Share Price Run

Boliden (OM:BOL) has drawn attention after a strong run in its share price over the past month and the past 3 months, prompting investors to reassess what the current valuation reflects. See our latest analysis for Boliden. That sharp 26.8% 1 month share price return and 60.3% 3 month share price return to SEK660.6 sits on top of a 97.5% 1 year total shareholder return, which points to strong momentum rather than a short term bounce. If Boliden’s surge has you thinking about where else...
NasdaqGS:THFF
NasdaqGS:THFFBanks

First Financial (THFF) Net Interest Margin Strength Supports Bullish Narratives In Q3 FY 2025

First Financial (THFF) just posted its FY 2025 third quarter numbers, with total revenue of US$69.3 million and basic EPS of US$1.75 setting the tone for its latest update. The company has seen quarterly revenue move from US$48.99 million in Q2 FY 2024 to US$69.3 million in Q3 FY 2025, while basic EPS has shifted from US$0.74 to US$1.75 over the same stretch, giving investors a clear view of how the income line has tracked alongside the top line. With a trailing twelve month net profit margin...
NasdaqGS:HTLD
NasdaqGS:HTLDTransportation

Heartland Express (HTLD) EPS Loss Persists In Q3 2025 And Reinforces Bearish Narratives

Heartland Express (HTLD) has opened FY 2025 with another tough quarter, reporting Q3 revenue of US$196.5 million and a basic EPS loss of US$0.11, alongside a trailing 12 month net loss of US$34.9 million on US$868.9 million of revenue. The company has seen quarterly revenue move from US$274.8 million in Q2 2024 to US$259.9 million in Q3 2024, then to US$242.6 million in Q4 2024 and US$219.4 million in Q1 2025, before landing at US$210.4 million in Q2 2025 and US$196.5 million in Q3 2025, with...
ENXTPA:PLX
ENXTPA:PLXDiversified Financial

Assessing Pluxee (ENXTPA:PLX) Valuation After Recent Share Price Weakness

With no single headline event driving attention, Pluxee (ENXTPA:PLX) is drawing interest after a period of weaker share performance, including a 16% decline over the past month and a 51% negative total return over the past year. See our latest analysis for Pluxee. That 15.63% 30 day share price decline and 33.39% 90 day share price return, alongside a 50.73% 1 year total shareholder return decline, points to fading momentum as investors reassess Pluxee’s risk and growth profile around its...
NYSE:PJT
NYSE:PJTCapital Markets

PJT Partners (PJT) Margin Improvement And 64.9% Earnings Growth Test Valuation Skeptics

PJT Partners (PJT) has put up another busy quarter, with Q3 FY 2025 revenue of US$446.9 million and basic EPS of US$1.55, alongside trailing 12 month EPS of US$6.95 on revenue of about US$1.66 billion and TTM earnings growth of 64.9% year over year. Over recent periods the firm has seen quarterly revenue move from US$326.1 million in Q3 2024 to US$478.6 million in Q4 2024, then to US$324.3 million in Q1 2025, US$406.7 million in Q2 2025 and US$446.9 million in Q3 2025, with EPS shifting from...
BIT:LDO
BIT:LDOAerospace & Defense

What Leonardo (BIT:LDO)'s India Helicopter Tie-Up With Adani Means For Shareholders

Italy's Leonardo and Adani Defence & Aerospace recently signed a preliminary agreement to create a helicopter manufacturing ecosystem in India, centred on the AW169M and AW109 TrekkerM models for military needs with potential civil applications. This partnership positions Leonardo inside India's growing domestic defence-industrial build‑out, giving it exposure to long-term helicopter demand identified by the Indian Armed Forces. Next, we examine how this planned India-based helicopter...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Is It Time To Reconsider Alvotech (ALVO) After Its Sharp Three-Year Share Price Slide?

Wondering whether Alvotech at US$5.32 is a bargain or a value trap? This article walks you through what the current price may be implying about the company. The stock has had a mixed run, with a 6.4% gain over the past month but a 57.0% loss over the last year and a 58.4% loss over three years, which can change how the market views its growth potential and risk. Recent coverage around Alvotech has focused on its position in biosimilars and its progress in bringing products to market, which...
TSX:RCI.B
TSX:RCI.BWireless Telecom

Rogers Post Shaw Deal Focuses On Synergies Valuation Gap And Deleveraging

Rogers Communications (TSX:RCI.B) is working through the post-acquisition integration of Shaw Communications following the recently completed deal. Management is highlighting cost synergy targets, disciplined pricing, and a focus on lowering debt as key priorities. Regulators continue to pay close attention to the combined business, particularly around competition and customer outcomes. For you as an investor, the Shaw acquisition is a major event because it reshapes Rogers Communications...
NasdaqGS:MZTI
NasdaqGS:MZTIFood

Marzetti (MZTI) Net Margin Around 8.7% Reinforces Premium Valuation Narratives

Marzetti (MZTI) has just posted another quarter of solid headline numbers, with Q2 2026 revenue of US$493.5 million and basic EPS of US$1.71, backed by trailing twelve month EPS of US$6.17 on US$1.94 billion in revenue. The company has seen revenue move from US$466.6 million in Q1 2025 to US$509.3 million in Q2 2025 and US$493.5 million in Q1 2026, while quarterly EPS has ranged between US$1.18 and US$1.78 over that span. This points to earnings power that aligns with an 8.7% net margin...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

How Investors May Respond To TeraWulf (WULF) Pivoting From Bitcoin Mining To AI Infrastructure Partnerships

In January, Needham analyst John Todaro reiterated his positive view on TeraWulf as the company shifts from traditional bitcoin mining toward high-performance computing and AI infrastructure, underpinned by contracted IT load and expansion plans. At the same time, Nvidia’s multibillion-dollar commitment to AI-focused cloud provider CoreWeave and TeraWulf’s partnerships with Fluidstack and Google highlighted how its repurposed industrial sites and planned 168-MW Texas facility link the...
TSX:SVM
TSX:SVMMetals and Mining

Is Silvercorp Metals (TSX:SVM) Quietly Reframing Its Risk Profile With The Condor PEA In Ecuador?

Silvercorp Metals Inc. has filed a Preliminary Economic Assessment for its Condor gold project in Ecuador, prepared by SRK Consulting (Canada) Inc. under NI 43-101 standards and now available on the company’s website, SEDAR, and EDGAR. This technical report adds another defined project to Silvercorp’s growing pipeline, alongside its planned US$150,000,000 investment in the Tulkubash open-pit/heap leach operation in the Kyrgyz Republic. We’ll now examine how advancing the Condor Preliminary...
TSE:5955
TSE:5955Machinery

Wise HoldingsLtd (TSE:5955) Margin Uptick And 30.6% Earnings Growth Test Bullish Narratives

Wise HoldingsLtd (TSE:5955) has posted Q3 2026 figures that put the focus squarely on its recent earnings pickup, with quarterly revenue of ¥3.2b and basic EPS of ¥0.80, while trailing twelve month earnings grew 30.6% and net profit margin on that basis stood at 2.8%. Over the past six quarters, the company has seen quarterly revenue move from ¥3.0b in Q2 2025 to ¥3.2b in Q3 2026, while basic EPS shifted from ¥0.44 to ¥0.80 and trailing twelve month EPS moved from ¥1.69 to ¥2.61. This sets up...
NYSE:IBP
NYSE:IBPConsumer Durables

Installed Building Products Expands Footprint With Targeted Insulation Acquisitions

Installed Building Products (NYSE:IBP) has acquired Thermo-Tech Mechanical Insulation, Biomax Spray Foam Insulation, and CKV Finished Products LLC. The transactions expand IBP's national footprint and broaden its mix across mechanical insulation, spray foam, and finishing services. These moves add to IBP's presence in both residential and commercial construction markets and increase operational diversification. Installed Building Products, listed on the NYSE under the ticker IBP, focuses on...
SEHK:386
SEHK:386Oil and Gas

How Investors Are Reacting To China Petroleum & Chemical (SEHK:386) Tilting Toward Petrochemicals Over Fuels

China Petroleum & Chemical Corporation recently reported its 2025 operating results, showing slightly higher crude oil and natural gas production but lower refinery throughput and reduced gasoline and diesel output compared with the prior year. The company’s downstream mix shifted, with jet-fuel-related kerosene and light chemical feedstocks increasing alongside higher ethylene and synthetic resin production, highlighting a tilt toward petrochemicals. We will now examine how this shift...
TSX:IAG
TSX:IAGInsurance

A Look At iA Financial (TSX:IAG) Valuation As P/E And DCF Send Mixed Signals

What stands out about iA Financial right now iA Financial (TSX:IAG) has caught investor attention after a period where the share price moved differently over the past month compared with the past 3 months and the past year. With a last close of CA$170.84 and a reported CA$1,091.0 net income on CA$8,755.0 revenue, investors are weighing how this established insurer and wealth manager compares with its recent return profile. See our latest analysis for iA Financial. Despite a recent 30 day...